[Treatment of suppurative meningitis due to multiresistant bacteria].
D000367:Age Factors; D002509:Cephaloridine / Q000627:therapeutic use*; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007612:Kanamycin / Q000627:therapeutic use*; D007945:Leukemia, Lymphoid / Q000150:complications; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D012475:Salmonella / Q000187:drug effects / Q000302:isolation & purification; D012705:Serratia / Q000187:drug effects / Q000302:isolation & purification; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification
D005839:Gentamicins; D007612:Kanamycin; D002701:Chloramphenicol; D002509:Cephaloridine
Traitement des méningites suppurées à germes multirésistants.